The role of D2-autoreceptors in regulating dopamine neuron activity and transmission

Neuroscience

Volumn 282, Issue , 2014, Pages 13-22

  Ford, C P ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cocaine; GPCR; Psychostimulants; Substantia nigra; VTA

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE AUTORECEPTOR; G PROTEIN COUPLED RECEPTOR; TYROSINE 3 MONOOXYGENASE; AUTORECEPTOR; DOPAMINE 1 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR;

ARTICLE; ATTENTION DEFICIT DISORDER; CELL FUNCTION; CORPUS STRIATUM; DENDRITE; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINE UPTAKE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; DRUG ABUSE; DRUG DEPENDENCE; ENZYME REGULATION; FEEDBACK SYSTEM; HUMAN; INHIBITORY POSTSYNAPTIC POTENTIAL; LIMBIC SYSTEM; LONG TERM DEPRESSION; NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; NERVE ENDING; NERVE FIBER; NEUROPHYSIOLOGY; NEUROTRANSMITTER RELEASE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SCHIZOPHRENIA; ANIMAL; METABOLISM; PHYSIOLOGY; REWARD; DOPAMINERGIC SYSTEM; LOCOMOTION; NEUROTRANSMISSION; REVIEW;

ANIMALS; AUTORECEPTORS; DOPAMINE; DOPAMINERGIC NEURONS; RECEPTORS, DOPAMINE D2; REWARD;

EID: 84906083161     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.01.025     Document Type: Review

References (143)

1. Adell A., Artigas F. The somatodendritic release of dopamine in the ventral tegmental area and its regulation by afferent transmitter systems. Neurosci Biobehav Rev 2004, 28:415-431.
2. Aghajanian G.K., Bunney B.S. Dopamine"autoreceptors": pharmacological characterization by microiontophoretic single cell recording studies. Naunyn Schmiedebergs Arch Pharmacol 1977, 297:1-7.
3. Anzalone A., Lizardi-Ortiz J.E., Ramos M., De Mei C., Hopf F.W., Iaccarino C., Halbout B., Jacobsen J., Kinoshita C., Welter M., Caron M.G., Bonci A., Sulzer D., Borrelli E. Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors. J Neurosci 2012, 32:9023-9034.
4. Baik J.H., Picetti R., Saiardi A., Thiriet G., Dierich A., Depaulis A., Le Meur M., Borrelli E. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 1995, 377:424-428.
5. Beaulieu J.M., Gainetdinov R.R. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 2011, 63:182-217.
6. Beckstead M.J., Williams J.T. Long-term depression of a dopamine IPSC. J Neurosci 2007, 27:2074-2080.
7. Beckstead M.J., Grandy D.K., Wickman K., Williams J.T. Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons. Neuron 2004, 42:939-946.
8. Beckstead M.J., Ford C.P., Phillips P.E., Williams J.T. Presynaptic regulation of dendrodendritic dopamine transmission. Eur J Neurosci 2007, 26:1479-1488.
9. Bello E.P., Mateo Y., Gelman D.M., Noain D., Shin J.H., Low M.J., Alvarez V.A., Lovinger D.M., Rubinstein M. Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptors. Nat Neurosci 2011, 14:1033-1038.
10. Benoit-Marand M., Borrelli E., Gonon F. Inhibition of dopamine release via presynaptic D2 receptors: time course and functional characteristics in vivo. J Neurosci 2001, 21:9134-9141.
11. Benoit-Marand M., Ballion B., Borrelli E., Boraud T., Gonon F. Inhibition of dopamine uptake by D2 antagonists: an in vivo study. J Neurochem 2011, 116:449-458.
12. Branch S.Y., Goertz R.B., Sharpe A.L., Pierce J., Roy S., Ko D., Paladini C.A., Beckstead M.J. Food restriction increases glutamate receptor-mediated burst firing of dopamine neurons. J Neurosci 2013, 33:13861-13872.
13. Bromberg-Martin E.S., Hikosaka O. Midbrain dopamine neurons signal preference for advance information about upcoming rewards. Neuron 2009, 63:119-126.
14. Buckholtz J.W., Treadway M.T., Cowan R.L., Woodward N.D., Li R., Ansari M.S., Baldwin R.M., Schwartzman A.N., Shelby E.S., Smith C.E., Kessler R.M., Zald D.H. Dopaminergic network differences in human impulsivity. Science 2010, 329:532.
15. Bulwa Z.B., Sharlin J.A., Clark P.J., Bhattacharya T.K., Kilby C.N., Wang Y., Rhodes J.S. Increased consumption of ethanol and sugar water in mice lacking the dopamine D2 long receptor. Alcohol 2011, 45:631-639.
16. Bunney B.S., Aghajanian G.K., Roth R.H. Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones. Nature 1973, 245:123-125.
17. Bunzow J.R., Van Tol H.H., Grandy D.K., Albert P., Salon J., Christie M., Machida C.A., Neve K.A., Civelli O. Cloning and expression of a rat D2 dopamine receptor cDNA. Nature 1988, 336:783-787.
18. Cardozo D.L., Bean B.P. Voltage-dependent calcium channels in rat midbrain dopamine neurons: modulation by dopamine and GABAB receptors. J Neurophysiol 1995, 74:1137-1148.
19. Cass W.A., Gerhardt G.A. Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake. Neurosci Lett 1994, 176:259-263.
20. Castro S.W., Strange P.G. Differences in the ligand binding properties of the short and long versions of the D2 dopamine receptor. J Neurochem 1993, 60:372-375.
21. Centonze D., Usiello A., Gubellini P., Pisani A., Borrelli E., Bernardi G., Calabresi P. Dopamine D2 receptor-mediated inhibition of dopaminergic neurons in mice lacking D2L receptors. Neuropsychopharmacology: official publication of the American College of. Neuropsychopharmacology 2002, 27:723-726.
22. Chausmer A.L., Elmer G.I., Rubinstein M., Low M.J., Grandy D.K., Katz J.L. Cocaine-induced locomotor activity and cocaine discrimination in dopamine D2 receptor mutant mice. Psychopharmacology 2002, 163:54-61.
23. Chen B.T., Rice M.E. Novel Ca2+ dependence and time course of somatodendritic dopamine release: substantia nigra versus striatum. J Neurosci 2001, 21:7841-7847.
24. Chen B.T., Rice M.E. Synaptic regulation of somatodendritic dopamine release by glutamate and GABA differs between substantia nigra and ventral tegmental area. J Neurochem 2002, 81:158-169.
25. Chen B.T., Moran K.A., Avshalumov M.V., Rice M.E. Limited regulation of somatodendritic dopamine release by voltage-sensitive Ca channels contrasted with strong regulation of axonal dopamine release. J Neurochem 2006, 96:645-655.
26. Cheramy A., Leviel V., Glowinski J. Dendritic release of dopamine in the substantia nigra. Nature 1981, 289:537-542.
27. Chiodo L.A., Bannon M.J., Grace A.A., Roth R.H., Bunney B.S. Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons. Neuroscience 1984, 12:1-16.
28. Cohen J.Y., Haesler S., Vong L., Lowell B.B., Uchida N. Neuron-type-specific signals for reward and punishment in the ventral tegmental area. Nature 2012, 482:85-88.
29. Congar P., Bergevin A., Trudeau L.E. D2 receptors inhibit the secretory process downstream from calcium influx in dopaminergic neurons: implication of K+ channels. J Neurophysiol 2002, 87:1046-1056.
30. Courtney N.A., Mamaligas A.A., Ford C.P. Species differences in somatodendritic dopamine transmission determine D2-autoreceptor mediated inhibition of ventral tegmental area neuron firing. J Neurosci 2012, 32:13520-13528.
31. Cunningham C.L., Howard M.A., Gill S.J., Rubinstein M., Low M.J., Grandy D.K. Ethanol-conditioned place preference is reduced in dopamine D2 receptor-deficient mice. Pharmacol Biochem Behav 2000, 67:693-699.
32. Dal Toso R., Sommer B., Ewert M., Herb A., Pritchett D.B., Bach A., Shivers B.D., Seeburg P.H. The dopamine D2 receptor: two molecular forms generated by alternative splicing. EMBO J 1989, 8:4025-4034.
33. Davila V., Yan Z., Craciun L.C., Logothetis D., Sulzer D. D3 dopamine autoreceptors do not activate G-protein-gated inwardly rectifying potassium channel currents in substantia nigra dopamine neurons. J Neurosci 2003, 23:5693-5697.
34. De Mei C., Ramos M., Iitaka C., Borrelli E. Getting specialized: presynaptic and postsynaptic dopamine D2 receptors. Curr Opin Pharmacol 2009, 9:53-58.
35. Delle Donne K.T., Sesack S.R., Pickel V.M. Ultrastructural immunocytochemical localization of neurotensin and the dopamine D2 receptor in the rat nucleus accumbens. J Comp Neurol 1996, 371:552-566.
36. Dickinson S.D., Sabeti J., Larson G.A., Giardina K., Rubinstein M., Kelly M.A., Grandy D.K., Low M.J., Gerhardt G.A., Zahniser N.R. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J Neurochem 1999, 72:148-156.
37. Feuerstein T.J. Presynaptic receptors for dopamine, histamine, and serotonin. Handb Exp Pharmacol 2008, 289-338.
38. Ford C.P., Beckstead M.J., Williams J.T. Kappa opioid inhibition of somatodendritic dopamine inhibitory postsynaptic currents. J Neurophysiol 2007, 97:883-891.
39. Ford C.P., Phillips P.E., Williams J.T. The time course of dopamine transmission in the ventral tegmental area. J Neurosci 2009, 29:13344-13352.
40. Ford C.P., Gantz S.C., Phillips P.E., Williams J.T. Control of extracellular dopamine at dendrite and axon terminals. J Neurosci 2010, 30:6975-6983.
41. Fulton S., Thibault D., Mendez J.A., Lahaie N., Tirotta E., Borrelli E., Bouvier M., Tempel B.L., Trudeau L.E. Contribution of Kv1.2 voltage-gated potassium channel to D2 autoreceptor regulation of axonal dopamine overflow. J Biol Chem 2011, 286:9360-9372.
42. Fuxe K., Agnati L.F. Volume transmission in the brain: novel mechanisms for neural transmission 1991, Raven Press, New York.
43. Gantz S.C., Bunzow J.R., Williams J.T. Spontaneous inhibitory synaptic currents mediated by a G protein-coupled receptor. Neuron 2013, 78:807-812.
44. Geffen L.B., Jessell T.M., Cuello A.C., Iversen L.L. Release of dopamine from dendrites in rat substantia nigra. Nature 1976, 260:258-260.
45. Giros B., Sokoloff P., Martres M.P., Riou J.F., Emorine L.J., Schwartz J.C. Alternative splicing directs the expression of two D2 dopamine receptor isoforms. Nature 1989, 342:923-926.
46. Grandy D.K., Marchionni M.A., Makam H., Stofko R.E., Alfano M., Frothingham L., Fischer J.B., Burke-Howie K.J., Bunzow J.R., Server A.C., et al. Cloning of the cDNA and gene for a human D2 dopamine receptor. Proc Natl Acad Sci U S A 1989, 86:9762-9766.
47. Groves P.M., Linder J.C. Dendro-dendritic synapses in substantia nigra: descriptions based on analysis of serial sections. Exp Brain Res 1983, 49:209-217.
48. Guiramand J., Montmayeur J.P., Ceraline J., Bhatia M., Borrelli E. Alternative splicing of the dopamine D2 receptor directs specificity of coupling to G-proteins. J Biol Chem 1995, 270:7354-7358.
49. Harada Wu.J., Haycock J.W., Goldstein M. Regulation of L-DOPA biosynthesis by site-specific phosphorylation of tyrosine hydroxylase in AtT-20 cells expressing wild-type and serine 40-substituted enzyme. J Neurochem 1996, 67:629-635.
50. Henry D.J., Greene M.A., White F.J. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: repeated administration. J Pharmacol Exp Ther 1989, 251:833-839.
51. Herlitze S., Garcia D.E., Mackie K., Hille B., Scheuer T., Catterall W.A. Modulation of Ca2+ channels by G-protein beta gamma subunits. Nature 1996, 380:258-262.
52. Hoffman A.F., Gerhardt G.A. Differences in pharmacological properties of dopamine release between the substantia nigra and striatum: an in vivo electrochemical study. J Pharmacol Exp Ther 1999, 289:455-463.
53. Huang C.L., Slesinger P.A., Casey P.J., Jan Y.N., Jan L.Y. Evidence that direct binding of G beta gamma to the GIRK1 G protein-gated inwardly rectifying K+ channel is important for channel activation. Neuron 1995, 15:1133-1143.
54. Ikeda S.R. Voltage-dependent modulation of N-type calcium channels by G-protein beta gamma subunits. Nature 1996, 380:255-258.
55. Jackson D.M., Westlind-Danielsson A. Dopamine receptors: molecular biology, biochemistry and behavioural aspects. Pharmacol Ther 1994, 64:291-370.
56. Jaffe E.H., Marty A., Schulte A., Chow R.H. Extrasynaptic vesicular transmitter release from the somata of substantia nigra neurons in rat midbrain slices. J Neurosci 1998, 18:3548-3553.
57. Jang J.Y., Jang M., Kim S.H., Um K.B., Kang Y.K., Kim H.J., Chung S., Park M.K. Regulation of dopaminergic neuron firing by heterogeneous dopamine autoreceptors in the substantia nigra pars compacta. J Neurochem 2011, 116:966-974.
58. Jones S., Kornblum J.L., Kauer J.A. Amphetamine blocks long-term synaptic depression in the ventral tegmental area. J Neurosci 2000, 20:5575-5580.
59. Kalivas P.W., Duffy P. A comparison of axonal and somatodendritic dopamine release using in vivo dialysis. J Neurochem 1991, 56:961-967.
60. Kalivas P.W., Lalumiere R.T., Knackstedt L., Shen H. Glutamate transmission in addiction. Neuropharmacology 2009, 56(Suppl. 1):169-173.
61. Kehr W., Carlsson A., Lindqvist M., Magnusson T., Atack C. Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity. J Pharm Pharmacol 1972, 24:744-747.
62. Kennedy R.T., Jones S.R., Wightman R.M. Dynamic observation of dopamine autoreceptor effects in rat striatal slices. J Neurochem 1992, 59:449-455.
63. Khan Z.U., Mrzljak L., Gutierrez A., de la Calle A., Goldman-Rakic P.S. Prominence of the dopamine D2 short isoform in dopaminergic pathways. Proc Natl Acad Sci U S A 1998, 95:7731-7736.
64. Kim K.M., Nakajima Y., Nakajima S. G protein-coupled inward rectifier modulated by dopamine agonists in cultured substantia nigra neurons. Neuroscience 1995, 69:1145-1158.
65. Koeltzow T.E., Xu M., Cooper D.C., Hu X.T., Tonegawa S., Wolf M.E., White F.J. Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice. J Neurosci 1998, 18:2231-2238.
66. Lacey M.G., Mercuri N.B., North R.A. Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta. J Physiol 1987, 392:397-416.
67. Lammel S., Hetzel A., Hackel O., Jones I., Liss B., Roeper J. Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system. Neuron 2008, 57:760-773.
68. Lammel S., Lim B.K., Malenka R.C. Reward and aversion in a heterogeneous midbrain dopamine system. Neuropharmacology 2013, 76:351-359.
69. Levant B. The D3 dopamine receptor: neurobiology and potential clinical relevance. Pharmacol Rev 1997, 49:231-252.
70. Li X., Qi J., Yamaguchi T., Wang H.L., Morales M. Heterogeneous composition of dopamine neurons of the rat A10 region: molecular evidence for diverse signaling properties. Brain Struct Funct 2013, 218:1159-1176.
71. Lindgren N., Xu Z.Q., Herrera-Marschitz M., Haycock J., Hokfelt T., Fisone G. Dopamine D(2) receptors regulate tyrosine hydroxylase activity and phosphorylation at Ser40 in rat striatum. Eur J Neurosci 2001, 13:773-780.
72. Lindgren N., Usiello A., Goiny M., Haycock J., Erbs E., Greengard P., Hokfelt T., Borrelli E., Fisone G. Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites. Proc Natl Acad Sci U S A 2003, 100:4305-4309.
73. Logothetis D.E., Kurachi Y., Galper J., Neer E.J., Clapham D.E. The beta gamma subunits of GTP-binding proteins activate the muscarinic K+ channel in heart. Nature 1987, 325:321-326.
74. Luscher C., Malenka R.C. Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron 2011, 69:650-663.
75. Luscher C., Slesinger P.A. Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease. Nat Rev Neurosci 2010, 11:301-315.
76. Madhavan A., Argilli E., Bonci A., Whistler J.L. Loss of D2 dopamine receptor function modulates cocaine-induced glutamatergic synaptic potentiation in the ventral tegmental area. J Neurosci 2013, 33:12329-12336.
77. Maldonado R., Saiardi A., Valverde O., Samad T.A., Roques B.P., Borrelli E. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 1997, 388:586-589.
78. Malmberg A., Jackson D.M., Eriksson A., Mohell N. Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors. Mol Pharmacol 1993, 43:749-754.
79. Marinelli M., White F.J. Enhanced vulnerability to cocaine self-administration is associated with elevated impulse activity of midbrain dopamine neurons. J Neurosci 2000, 20:8876-8885.
80. Marinelli M., Cooper D.C., Baker L.K., White F.J. Impulse activity of midbrain dopamine neurons modulates drug-seeking behavior. Psychopharmacology 2003, 168:84-98.
81. Martel P., Leo D., Fulton S., Berard M., Trudeau L.E. Role of Kv1 potassium channels in regulating dopamine release and presynaptic D2 receptor function. PLoS One 2011, 6:e20402.
82. Mayfield R.D., Zahniser N.R. Dopamine D2 receptor regulation of the dopamine transporter expressed in Xenopus laevis oocytes is voltage-independent. Mol Pharmacol 2001, 59:113-121.
83. McCutcheon J.E., White F.J., Marinelli M. Individual differences in dopamine cell neuroadaptations following cocaine self-administration. Biol Psychiatry 2009, 66:801-803.
84. Mercuri N.B., Saiardi A., Bonci A., Picetti R., Calabresi P., Bernardi G., Borrelli E. Loss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice. Neuroscience 1997, 79:323-327.
85. Missale C., Nash S.R., Robinson S.W., Jaber M., Caron M.G. Dopamine receptors: from structure to function. Physiol Rev 1998, 78:189-225.
86. Monsma F.J., McVittie L.D., Gerfen C.R., Mahan L.C., Sibley D.R. Multiple D2 dopamine receptors produced by alternative RNA splicing. Nature 1989, 342:926-929.
87. Montmayeur J.P., Borrelli E. Transcription mediated by a cAMP-responsive promoter element is reduced upon activation of dopamine D2 receptors. Proc Natl Acad Sci U S A 1991, 88:3135-3139.
88. Montmayeur J.P., Guiramand J., Borrelli E. Preferential coupling between dopamine D2 receptors and G-proteins. Mol Endocrinol 1993, 7:161-170.
89. Nestler E.J. Is there a common molecular pathway for addiction?. Nat Neurosci 2005, 8:1445-1449.
90. Neve K.A., Seamans J.K., Trantham-Davidson H. Dopamine receptor signaling. J Recept Signal Transduct Res 2004, 24:165-205.
91. Neve K.A., Ford C.P., Buck D.C., Grandy D.K., Neve R.L., Phillips T.J. Normalizing dopamine D2 receptor-mediated responses in D2 null mutant mice by virus-mediated receptor restoration: Comparing D2 and D2. Neuroscience 2013, 248C:479-487.
92. Nirenberg M.J., Chan J., Liu Y., Edwards R.H., Pickel V.M. Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: potential sites for somatodendritic storage and release of dopamine. J Neurosci 1996, 16:4135-4145.
93. Nirenberg M.J., Vaughan R.A., Uhl G.R., Kuhar M.J., Pickel V.M. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J Neurosci 1996, 16:436-447.
94. O'Hara C.M., Uhland-Smith A., O'Malley K.L., Todd R.D. Inhibition of dopamine synthesis by dopamine D2 and D3 but not D4 receptors. J Pharmacol Exp Ther 1996, 277:186-192.
95. Onali P., Olianas M.C. Involvement of adenylate cyclase inhibition in dopamine autoreceptor regulation of tyrosine hydroxylase in rat nucleus accumbens. Neurosci Lett 1989, 102:91-96.
96. Palij P., Bull D.R., Sheehan M.J., Millar J., Stamford J., Kruk Z.L., Humphrey P.P. Presynaptic regulation of dopamine release in corpus striatum monitored in vitro in real time by fast cyclic voltammetry. Brain Res 1990, 509:172-174.
97. Perra S., Clements M.A., Bernier B.E., Morikawa H. In vivo ethanol experience increases D(2) autoinhibition in the ventral tegmental area. Neuropsychopharmacology: official publication of the American College of. Neuropsychopharmacology 2011, 36:993-1002.
98. Pfaffinger P.J., Martin J.M., Hunter D.D., Nathanson N.M., Hille B. GTP-binding proteins couple cardiac muscarinic receptors to a K channel. Nature 1985, 317:536-538.
99. Phillips P.E., Stamford J.A. Differential recruitment of N-, P- and Q-type voltage-operated calcium channels in striatal dopamine release evoked by 'regular' and 'burst' firing. Brain Res 2000, 884:139-146.
100. Phillips T.J., Brown K.J., Burkhart-Kasch S., Wenger C.D., Kelly M.A., Rubinstein M., Grandy D.K., Low M.J. Alcohol preference and sensitivity are markedly reduced in mice lacking dopamine D2 receptors. Nat Neurosci 1998, 1:610-615.
101. Phillips P.E., Hancock P.J., Stamford J.A. Time window of autoreceptor-mediated inhibition of limbic and striatal dopamine release. Synapse 2002, 44:15-22.
102. Phillips P.E., Stuber G.D., Heien M.L., Wightman R.M., Carelli R.M. Subsecond dopamine release promotes cocaine seeking. Nature 2003, 422:614-618.
103. Pothos E.N., Przedborski S., Davila V., Schmitz Y., Sulzer D. D2-Like dopamine autoreceptor activation reduces quantal size in PC12 cells. J Neurosci 1998, 18:5575-5585.
104. Prasad B.M., Amara S.G. The dopamine transporter in mesencephalic cultures is refractory to physiological changes in membrane voltage. J Neurosci 2001, 21:7561-7567.
105. Reuveny E., Slesinger P.A., Inglese J., Morales J.M., Iniguez-Lluhi J.A., Lefkowitz R.J., Bourne H.R., Jan Y.N., Jan L.Y. Activation of the cloned muscarinic potassium channel by G protein beta gamma subunits. Nature 1994, 370:143-146.
106. Rice M.E., Cragg S.J. Dopamine spillover after quantal release: Rethinking dopamine transmission in the nigrostriatal pathway. Brain Res Rev 2008, 58:303-313.
107. Rice M.E., Richards C.D., Nedergaard S., Hounsgaard J., Nicholson C., Greenfield S.A. Direct monitoring of dopamine and 5-HT release in substantia nigra and ventral tegmental area in vitro. Exp Brain Res 1994, 100:395-406.
108. Riven I., Iwanir S., Reuveny E. GIRK channel activation involves a local rearrangement of a preformed G protein channel complex. Neuron 2006, 51:561-573.
109. Rivet J.M., Audinot V., Gobert A., Peglion J.L., Millan M.J. Modulation of mesolimbic dopamine release by the selective dopamine D3 receptor antagonist, (+)-S 14297. Eur J Pharmacol 1994, 265:175-177.
110. Romanelli R.J., Williams J.T., Neve K.A. Dopamine receptor signaling: intracellular pathways to behavior. The dopamine receptors 2010, 137-174. Humana Press, Portland, OR. K.A. Neve (Ed.).
111. Rouge-Pont F., Usiello A., Benoit-Marand M., Gonon F., Piazza P.V., Borrelli E. Changes in extracellular dopamine induced by morphine and cocaine: crucial control by D2 receptors. J Neurosci 2002, 22:3293-3301.
112. Saal D., Dong Y., Bonci A., Malenka R.C. Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 2003, 37:577-582.
113. Schmitz Y., Schmauss C., Sulzer D. Altered dopamine release and uptake kinetics in mice lacking D2 receptors. J Neurosci 2002, 22:8002-8009.
114. Schmitz Y., Benoit-Marand M., Gonon F., Sulzer D. Presynaptic regulation of dopaminergic neurotransmission. J Neurochem 2003, 87:273-289.
115. Schoffelmeer A.N., Hogenboom F., Mulder A.H., Ronken E., Stoof J.C., Drukarch B. Dopamine displays an identical apparent affinity towards functional dopamine D1 and D2 receptors in rat striatal slices: possible implications for the regulatory role of D2 receptors. Synapse 1994, 17:190-195.
116. Seeman P., Lee T. Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. Science 1975, 188:1217-1219.
117. Senogles S.E. The D2 dopamine receptor isoforms signal through distinct Gi alpha proteins to inhibit adenylyl cyclase. A study with site-directed mutant Gi alpha proteins. J Biol Chem 1994, 269:23120-23127.
118. Sesack S.R., Aoki C., Pickel V.M. Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J Neurosci 1994, 14:88-106.
119. Sibley D.R., De Lean A., Creese I. Anterior pituitary dopamine receptors. Demonstration of interconvertible high and low affinity states of the D-2 dopamine receptor. J Biol Chem 1982, 257:6351-6361.
120. Sibley D.R., Mahan L.C., Creese I. Dopamine receptor binding on intact cells. Absence of a high-affinity agonist-receptor binding state. Mol Pharmacol 1983, 23:295-302.
121. Skinbjerg M., Sibley D.R., Javitch J.A., Abi-Dargham A. Imaging the high-affinity state of the dopamine D2 receptor in vivo: fact or fiction?. Biochem Pharmacol 2012, 83:193-198.
122. Sodickson D.L., Bean B.P. GABAB receptor-activated inwardly rectifying potassium current in dissociated hippocampal CA3 neurons. J Neurosci 1996, 16:6374-6385.
123. Sodickson D.L., Bean B.P. Neurotransmitter activation of inwardly rectifying potassium current in dissociated hippocampal CA3 neurons: interactions among multiple receptors. J Neurosci 1998, 18:8153-8162.
124. Sonders M.S., Zhu S.J., Zahniser N.R., Kavanaugh M.P., Amara S.G. Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants. J Neurosci 1997, 17:960-974.
125. Stamford J.A., Kruk Z.L., Millar J. Differential effects of dopamine agonists upon stimulated limbic and striatal dopamine release: in vivo voltammetric data. Br J Pharmacol 1991, 102:45-50.
126. Suaud-Chagny M.F., Ponec J., Gonon F. Presynaptic autoinhibition of the electrically evoked dopamine release studied in the rat olfactory tubercle by in vivo electrochemistry. Neuroscience 1991, 45:641-652.
127. Surmeier D.J., Shen W., Day M., Gertler T., Chan S., Tian X., Plotkin J.L. The role of dopamine in modulating the structure and function of striatal circuits. Prog Brain Res 2010, 183:149-167.
128. Surprenant A., North R.A. Mechanism of synaptic inhibition by noradrenaline acting at alpha 2-adrenoceptors. Proc R Soc Lond B Biol Sci 1988, 234:85-114.
129. Tobler P.N., Fiorillo C.D., Schultz W. Adaptive coding of reward value by dopamine neurons. Science 2005, 307:1642-1645.
130. Truong J.G., Newman A.H., Hanson G.R., Fleckenstein A.E. Dopamine D2 receptor activation increases vesicular dopamine uptake and redistributes vesicular monoamine transporter-2 protein. Eur J Pharmacol 2004, 504:27-32.
131. Ungless M.A., Whistler J.L., Malenka R.C., Bonci A. Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature 2001, 411:583-587.
132. Usiello A., Baik J.H., Rouge-Pont F., Picetti R., Dierich A., LeMeur M., Piazza P.V., Borrelli E. Distinct functions of the two isoforms of dopamine D2 receptors. Nature 2000, 408:199-203.
133. van Wieringen J.P., Booij J., Shalgunov V., Elsinga P., Michel M.C. Agonist high- and low-affinity states of dopamine D(2) receptors: methods of detection and clinical implications. Naunyn Schmiedebergs Arch Pharmacol 2013, 386:135-154.
134. Wang Y., Xu R., Sasaoka T., Tonegawa S., Kung M.P., Sankoorikal E.B. Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions. J Neurosci 2000, 20:8305-8314.
135. Whorton M.R., MacKinnon R. X-ray structure of the mammalian GIRK2-betagamma G-protein complex. Nature 2013, 498:190-197.
136. Wickman K.D., Iniguez-Lluhl J.A., Davenport P.A., Taussig R., Krapivinsky G.B., Linder M.E., Gilman A.G., Clapham D.E. Recombinant G-protein beta gamma-subunits activate the muscarinic-gated atrial potassium channel. Nature 1994, 368:255-257.
137. Wilson C.J., Groves P.M., Fifkova E. Monoaminergic synapses, including dendro-dendritic synapses in the rat substantia nigra. Exp Brain Res 1977, 30:161-174.
138. Wolf M.E., Roth R.H. Autoreceptor regulation of dopamine synthesis. Ann N Y Acad Sci 1990, 604:323-343.
139. Wolf M.E., White F.J., Nassar R., Brooderson R.J., Khansa M.R. Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J Pharmacol Exp Ther 1993, 264:249-255.
140. Wu L.G., Saggau P. Presynaptic inhibition of elicited neurotransmitter release. Trends Neurosci 1997, 20:204-212.
141. Wu Q., Reith M.E., Walker Q.D., Kuhn C.M., Carroll F.I., Garris P.A. Concurrent autoreceptor-mediated control of dopamine release and uptake during neurotransmission: an in vivo voltammetric study. J Neurosci 2002, 22:6272-6281.
142. Yokoo H., Goldstein M., Meller E. Receptor reserve at striatal dopamine receptors modulating the release of [3H]dopamine. Eur J Pharmacol 1988, 155:323-327.
143. Zald D.H., Cowan R.L., Riccardi P., Baldwin R.M., Ansari M.S., Li R., Shelby E.S., Smith C.E., McHugo M., Kessler R.M. Midbrain dopamine receptor availability is inversely associated with novelty-seeking traits in humans. J Neurosci 2008, 28:14372-14378.